| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |